生命科学资讯

Regulatory actions for March 3, 2026

WAT - Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results - ADVFN Ltd

PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub - Zacks Investment Research

Boehringer Ingelheim tried to use a tempting, tough cancer target for liver disease. It didn’t work

Hims partner Strive Pharmacy will reintroduce GLP-1 pill pulled from market

TXG Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

CMS' Chris Klomp on what it will take for AI to succeed in healthcare

Deep learning in biology faces a transferability crisis

Magnesium depletion by Candida albicans unleashes two unusual modes of colistin resistance in Pseudomonas aeruginosa with different fitness costs

Glutamatergic projections from the substantia nigra pars reticulata to the dorsal raphe nucleus regulate male social hierarchies

Developing monoclonal antibody therapies for measles could lead to adverse pathogen evolution

J&J’s blockbuster Spravato is setting the stage for managing psychedelics’ risks

AI musculoskeletal imaging medtechs Medimaps and Radiobotics pen merger deal

Esperion to buy Corstasis and its nasal spray for edema for $75M upfront

10x Genomics, Inc. (TXG) Stock Analysis: A Closer Look at the Healthcare Innovator’s Growth Potential and Analyst Ratings - DirectorsTalk Interviews

Morgan Stanley Lowers Price Target on Agilent Technologies to $160 From $180, Keeps Overweight Rating - marketscreener.com

Champlain Investment Partners LLC Has $114.97 Million Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat

Champlain Investment Partners LLC Sells 94,439 Shares of Waters Corporation $WAT - MarketBeat

Roche: Sustainable Operations, Supply Chains & AI in Health - Sustainability Magazine

GLP-1s support heart attack recovery in rodents by relaxing tight blood vessels